These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25374442)

  • 61. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome.
    Johnsen S; Dolan SE; Fitch KV; Kanter JR; Hemphill LC; Connelly JM; Lees RS; Lee H; Grinspoon S
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4916-24. PubMed ID: 17003092
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection.
    Lee SA; Sinclair E; Jain V; Huang Y; Epling L; Van Natta M; Meinert CL; Martin JN; McCune JM; Deeks SG; Lederman MM; Hecht FM; Hunt PW
    J Infect Dis; 2014 Aug; 210(3):374-82. PubMed ID: 24585893
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV.
    Negredo E; Jiménez M; Puig J; Loste C; Pérez-Álvarez N; Urrea V; Echeverría P; Bonjoch A; Clotet B; Blanco J
    PLoS One; 2020; 15(9):e0238575. PubMed ID: 32941476
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis.
    Sacre K; Hunt PW; Hsue PY; Maidji E; Martin JN; Deeks SG; Autran B; McCune JM
    AIDS; 2012 Apr; 26(7):805-14. PubMed ID: 22313962
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comprehensive evaluation of the immune risk phenotype in successfully treated HIV-infected individuals.
    Ndumbi P; Gilbert L; Tsoukas CM
    PLoS One; 2015; 10(2):e0117039. PubMed ID: 25647167
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inflammation, Immune Activation, Immunosenescence, and Hormonal Biomarkers in the Frailty-Related Phenotype of Men With or at Risk for HIV Infection.
    Erlandson KM; Ng DK; Jacobson LP; Margolick JB; Dobs AS; Palella FJ; Lake JE; Bui H; Kingsley L; Brown TT
    J Infect Dis; 2017 Jan; 215(2):228-237. PubMed ID: 27799351
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Carotid intima-media thickness and arterial stiffness in HIV-infected patients: the role of HIV, antiretroviral therapy, and lipodystrophy.
    van Vonderen MG; Smulders YM; Stehouwer CD; Danner SA; Gundy CM; Vos F; Reiss P; Agtmael MA
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):153-61. PubMed ID: 19131894
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Altered T cell differentiation associated with loss of CD27 and CD28 in HIV infected Indian individuals.
    Mojumdar K; Vajpayee M; Chauhan NK; Singh A; Singh R; Kurapati S
    Cytometry B Clin Cytom; 2012 Jan; 82(1):43-53. PubMed ID: 21695776
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reduction in terminally differentiated T cells in virologically controlled HIV-infected aging patients on long-term antiretroviral therapy.
    Behrens NE; Wertheimer A; Klotz SA; Ahmad N
    PLoS One; 2018; 13(6):e0199101. PubMed ID: 29897981
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy.
    Lim A; French MA; Price P
    J Acquir Immune Defic Syndr; 2009 Jul; 51(3):248-57. PubMed ID: 19363449
    [TBL] [Abstract][Full Text] [Related]  

  • 72. T-cell activation, both pre- and post-HAART levels, correlates with carotid artery stiffness over 6.5 years among HIV-infected women in the WIHS.
    Karim R; Mack WJ; Kono N; Tien PC; Anastos K; Lazar J; Young M; Desai S; Golub ET; Kaplan RC; Hodis HN; Kovacs A
    J Acquir Immune Defic Syndr; 2014 Nov; 67(3):349-56. PubMed ID: 25314253
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term changes in carotid intima-media thickness among HIV-infected children and young adults.
    Ross Eckard A; O'Riordan MA; Storer N; McComsey GA
    Antivir Ther; 2014; 19(1):61-8. PubMed ID: 23985545
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection.
    Amu S; Lantto Graham R; Bekele Y; Nasi A; Bengtsson C; Rethi B; Sorial S; Meini G; Zazzi M; Hejdeman B; Chiodi F
    Medicine (Baltimore); 2016 Jun; 95(23):e3738. PubMed ID: 27281071
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms.
    Serrano-Villar S; Estrada V; Gómez-Garre D; Ávila M; Fuentes-Ferrer M; San RJ; Soriano V; Sánchez-Parra C; Sainz T; Fernández-Cruz A
    Eur J Prev Cardiol; 2014 Jun; 21(6):739-48. PubMed ID: 22718798
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Osteoprotegerin and osteocalcin are associated with atherosclerosis in patients with rheumatoid arthritis: a prospective cohort study.
    Wahlin B; Ramnemark A; Rantapää-Dahlqvist S; Wållberg-Jonsson S; Södergren A
    Clin Exp Rheumatol; 2021; 39(6):1402-1409. PubMed ID: 33635235
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Low Frequency of IL-17-Producing CD8
    Perdomo-Celis F; Feria MG; Taborda NA; Rugeles MT
    Front Immunol; 2018; 9():2502. PubMed ID: 30420859
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial.
    Nakanjako D; Ssinabulya I; Nabatanzi R; Bayigga L; Kiragga A; Joloba M; Kaleebu P; Kambugu AD; Kamya MR; Sekaly R; Elliott A; Mayanja-Kizza H
    Trop Med Int Health; 2015 Mar; 20(3):380-90. PubMed ID: 25441397
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
    Bouscarat F; Levacher-Clergeot M; Dazza MC; Strauss KW; Girard PM; Ruggeri C; Sinet M
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):17-24. PubMed ID: 8825614
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD Collaborative.
    Hanna DB; Guo M; Bůžková P; Miller TL; Post WS; Stein JH; Currier JS; Kronmal RA; Freiberg MS; Bennett SN; Shikuma CM; Anastos K; Li Y; Tracy RP; Hodis HN; Delaney JA; Kaplan RC
    Clin Infect Dis; 2016 Jul; 63(2):249-56. PubMed ID: 27118787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.